[Description and study of risk factors for the diagnostic delay of pediatric inflammatory bowel disease]

J V Arcos-Machancoses1, E Donat-Aliaga1, B Polo-Miquel1

  • 1Unidad de Gastroenterología y Hepatología Pediátrica, Hospital Universitario y Politécnico La Fe, Valencia, España.

Insights

Diagnostic delays in pediatric inflammatory bowel disease (IBD) are common, with a significant percentage of children experiencing delays over a year. While the median delay is 12 weeks, further investigation into missed diagnostic opportunities is crucial for improving outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Diagnostic Timeliness

Background:

  • Diagnostic delay in pediatric inflammatory bowel disease (IBD) can lead to complications and reduced treatment efficacy.
  • Understanding diagnostic delay factors is essential for implementing improvements and enhancing patient prognosis.

Purpose of the Study:

  • To evaluate the diagnostic delay in pediatric inflammatory bowel disease (IBD).
  • To identify factors contributing to diagnostic delays in children with IBD.

Main Methods:

  • Retrospective analysis of 53 pediatric IBD patients' medical records (2000-2012).
  • Data collected from primary care and a tertiary hospital's pediatric gastroenterology service.
  • Primary outcome measured: time from initial physician contact to diagnosis.

Main Results:

  • Median diagnostic delay for pediatric IBD was 12 weeks.
  • Over 25% of Crohn's disease and ulcerative colitis cases exceeded a 1-year diagnostic interval.
  • No specific risk factors were significantly associated with delay, though younger children trended towards longer delays.

Conclusions:

  • While the median diagnostic delay for pediatric IBD may appear acceptable, a substantial proportion of children face considerable delays.
  • Heterogeneous clinical presentations in pediatric IBD contribute to diagnostic challenges.
  • Further research is warranted to identify and address "lost diagnostic opportunities" to improve timely diagnosis and management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
21
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
27
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
21